Report overview
On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the extension of current therapies are fueling the growth of the market. However, high cost associated with therapy, a stringent regulatory environment, and the lack of awareness in the general population could adversely affect market growth.
This report aims to provide a comprehensive presentation of the global market for Skin Cancer Diagnostics and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Skin Cancer Diagnostics and Therapeutics. This report contains market size and forecasts of Skin Cancer Diagnostics and Therapeutics in global, including the following market information:
Global Skin Cancer Diagnostics and Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Skin Cancer Diagnostics and Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In 2017, North America was the largest regional market, in terms of revenue. The high prevalence of skin cancer and its risk factors, a favorable reimbursement environment, and high adoption rate of novel technologies are primary factors behind the large market size. The Asia-Pacific region is expected to grow at a rapid pace over the forecast period, owing to increasing healthcare expenditure and government initiatives aimed at increasing awareness in the developing economies of the region.
We surveyed the Skin Cancer Diagnostics and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Skin Cancer Diagnostics and Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Skin Cancer Diagnostics and Therapeutics Market Segment Percentages, by Type, 2022 (%)
Basal Cell Carcinoma
Squamous Cell Carcinoma
Melanoma
Global Skin Cancer Diagnostics and Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Skin Cancer Diagnostics and Therapeutics Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Cancer Research Center
Others
Global Skin Cancer Diagnostics and Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Skin Cancer Diagnostics and Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Skin Cancer Diagnostics and Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Skin Cancer Diagnostics and Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Merck
Novartis
Pfizer
Qiagen
Roche
Sanofi
Abbott
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Outline of Major Chapters:
Chapter 1: Introduces the definition of Skin Cancer Diagnostics and Therapeutics, market overview.
Chapter 2: Global Skin Cancer Diagnostics and Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Skin Cancer Diagnostics and Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Skin Cancer Diagnostics and Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
